Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Computed Tomography | Case report

An unusual case of reactivated latent pulmonary cryptococcal infection in a patient after short‐term steroid and azathioprine therapy: a case report

Authors: Wei-Gang Pan, Bao-Chung Chen, Yao-Feng Li, Rui-Xin Wu, Ching-Hsun Wang

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Cryptococcus is one of the major fungal pathogens infecting the lungs. Pulmonary cryptococcal infection is generally considered a community-acquired condition caused by inhalation of dust contaminated with fungal cells from the environment. Here, we report a case developing pulmonary cryptococcosis 3 months after hospital admission, which has rarely been reported before.

Case presentation

A 73-year-old female patient who was previously immunocompetent experienced persistent dry cough for 2 weeks, 3 months after admission. Chest computed tomography (CT) showed a new solitary pulmonary nodule developed in the upper lobe of the left lung. Staining and culture of expectorated sputum smears were negative for bacteria, acid-fast bacilli, or fungus. The patient then underwent biopsy of the lesion. Histopathology findings and a positive serum cryptococcal antigen titer (1:8) indicated pulmonary cryptococcosis. Daily intravenous 400 mg fluconazole was administered initially followed by oral fluconazole therapy. Follow-up chest CT after 3 months of antifungal therapy showed complete disappearance of the pulmonary nodule. Respiratory symptoms of the patient also resolved. A complete investigation excluded the possibility of a patient-to-patient transmission or primarily acquiring the infection from the hospital environment. Based on the patient’s history of exposure to pigeons before admission and recent steroid and azathioprine use after admission for the treatment of myasthenic crisis, reactivation of a latent pulmonary cryptococcal infection acquired before admission, in this case, is impressed.

Conclusions

Although rarely reported, pulmonary cryptococcal infection should be included in the differential diagnosis of hospitalized patients with respiratory symptoms, especially in those with predisposing risk factors. Chest image studies and further surgical biopsy are needed for confirmation.
Literature
1.
go back to reference May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106–17.CrossRef May RC, Stone NR, Wiesner DL, Bicanic T, Nielsen K. Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol. 2016;14(2):106–17.CrossRef
2.
go back to reference Glaser JB, Garden A. Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome. N Engl J Med. 1985;313(4):266.PubMed Glaser JB, Garden A. Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome. N Engl J Med. 1985;313(4):266.PubMed
3.
go back to reference Sirinavin S, Intusoma U, Tuntirungsee S. Mother-to-child transmission of cryptococcus neoformans. Pediatr Infect Dis J. 2004;23(3):278–9.CrossRef Sirinavin S, Intusoma U, Tuntirungsee S. Mother-to-child transmission of cryptococcus neoformans. Pediatr Infect Dis J. 2004;23(3):278–9.CrossRef
4.
go back to reference Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45(4):321–46.CrossRef Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007;45(4):321–46.CrossRef
5.
go back to reference Richardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect. 2008;14(Suppl 4):5–24.CrossRef Richardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect. 2008;14(Suppl 4):5–24.CrossRef
6.
go back to reference Wang CY, Wu HD, Hsueh PR. Nosocomial transmission of cryptococcosis. N Engl J Med. 2005;352(12):1271–2.CrossRef Wang CY, Wu HD, Hsueh PR. Nosocomial transmission of cryptococcosis. N Engl J Med. 2005;352(12):1271–2.CrossRef
7.
go back to reference Roberts SH, Gault MH, Fardy PW. Occurrence of two cases of cryptococcosis within 3 months on the same general medical ward. Can Med Assoc J. 1976;115(6):537–8.PubMedPubMedCentral Roberts SH, Gault MH, Fardy PW. Occurrence of two cases of cryptococcosis within 3 months on the same general medical ward. Can Med Assoc J. 1976;115(6):537–8.PubMedPubMedCentral
8.
go back to reference Rustan ME, Rubinstein HR, Siciliano C, Masih DT. Possibility of in-hospital infection by Cryptococcus neoformans in patients with AIDS. Rev Inst Med Trop Sao Paulo. 1992;34(5):383–7.CrossRef Rustan ME, Rubinstein HR, Siciliano C, Masih DT. Possibility of in-hospital infection by Cryptococcus neoformans in patients with AIDS. Rev Inst Med Trop Sao Paulo. 1992;34(5):383–7.CrossRef
9.
go back to reference Maziarz EK, Perfect JR, Cryptococcosis. Infect Dis Clin N Am. 2016;30(1):179–206.CrossRef Maziarz EK, Perfect JR, Cryptococcosis. Infect Dis Clin N Am. 2016;30(1):179–206.CrossRef
10.
go back to reference Clift SA, Bradsher RW, Chan CH. Peritonitis as an indicator of disseminated cryptococcal infection. Am J Gastroenterol. 1982;77(12):922–4.PubMed Clift SA, Bradsher RW, Chan CH. Peritonitis as an indicator of disseminated cryptococcal infection. Am J Gastroenterol. 1982;77(12):922–4.PubMed
11.
go back to reference Kauffman CA, Severance PJ. Nosocomial cryptococcal infection. South Med J. 1980;73(2):267.CrossRef Kauffman CA, Severance PJ. Nosocomial cryptococcal infection. South Med J. 1980;73(2):267.CrossRef
12.
go back to reference Vallabhaneni S, Haselow D, Lloyd S, Lockhart S, Moulton-Meissner H, Lester L, et al. Cluster of Cryptococcus neoformans infections in intensive care unit, Arkansas, USA, 2013. Emerg Infect Dis. 2015;21(10):1719–24.CrossRef Vallabhaneni S, Haselow D, Lloyd S, Lockhart S, Moulton-Meissner H, Lester L, et al. Cluster of Cryptococcus neoformans infections in intensive care unit, Arkansas, USA, 2013. Emerg Infect Dis. 2015;21(10):1719–24.CrossRef
13.
go back to reference Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33(5):690–9.CrossRef Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33(5):690–9.CrossRef
14.
go back to reference Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84(3):304–15.CrossRef Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84(3):304–15.CrossRef
15.
go back to reference Nidhi A, Meena A, Sreekumar A, Daga MK. Corticosteroid-induced cryptococcal meningitis in patient without HIV. BMJ Case Rep. 2017; 2017:bcr2016216496.CrossRef Nidhi A, Meena A, Sreekumar A, Daga MK. Corticosteroid-induced cryptococcal meningitis in patient without HIV. BMJ Case Rep. 2017; 2017:bcr2016216496.CrossRef
16.
go back to reference Wilson TS, Fleming WA, Robinson FL, Nicholl B. Cryptococcal meningitis associated with steroid therapy. J Clin Pathol. 1970;23(8):657–63.CrossRef Wilson TS, Fleming WA, Robinson FL, Nicholl B. Cryptococcal meningitis associated with steroid therapy. J Clin Pathol. 1970;23(8):657–63.CrossRef
17.
go back to reference Sethi NK, Torgovnick J, Sethi PK. Cryptococcal meningitis after Imuran (azathioprine) therapy for autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2007;19(10):913–14.CrossRef Sethi NK, Torgovnick J, Sethi PK. Cryptococcal meningitis after Imuran (azathioprine) therapy for autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2007;19(10):913–14.CrossRef
Metadata
Title
An unusual case of reactivated latent pulmonary cryptococcal infection in a patient after short‐term steroid and azathioprine therapy: a case report
Authors
Wei-Gang Pan
Bao-Chung Chen
Yao-Feng Li
Rui-Xin Wu
Ching-Hsun Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01444-3

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.